Back to Companies
BridgeBio Pharma, Inc.
BBIONasdaqCIK: 0001743881
Over the 50 most recent insider filings, BridgeBio Pharma, Inc. (BBIO) has seen activity from 16 distinct insiders — all of them on the sell side. The activity is heavily weighted toward selling: $0 bought versus $83.5M sold, net sales of $83.5M. Kumar Neil (Chief Executive Officer, Director) is the most active by dollar volume, and the single largest transaction was $20.6M by Cook Jennifer E.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$123.5M
Purchases
$0
Sales
$83.5M
Unique Insiders
16
Recent Insider Trades
50 loaded
| Aug 18 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Exercise | $2.9M |
| Aug 18 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | Tax withheld | $1.8M |
| Aug 18 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Tax withheld | $376.5K |
| Aug 3 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Sell | $160.1K |
| Jul 13 | BBIO BridgeBio Pharma, Inc. | Cook Jennifer E. | Director | Sell | $13.2M |
| Jul 13 | BBIO BridgeBio Pharma, Inc. | Ellis Andrea | Director | Sell | $1.4M |
| Jun 24 | BBIO BridgeBio Pharma, Inc. | HOMCY CHARLES J | Director | Grant | $363.7K |
| Jun 24 | BBIO BridgeBio Pharma, Inc. | Lo Andrew | Director | Grant | $363.7K |
| Jun 24 | BBIO BridgeBio Pharma, Inc. | DANIELS RONALD J | Director | Grant | $363.7K |
| Jun 24 | BBIO BridgeBio Pharma, Inc. | Satvat Ali J. | Director | Grant | $363.7K |
| Jun 24 | BBIO BridgeBio Pharma, Inc. | AGUIAR ERIC | Director | Grant | $363.7K |
| Jun 24 | BBIO BridgeBio Pharma, Inc. | Cook Jennifer E. | Director | Sell | $2.8M |
| Jun 24 | BBIO BridgeBio Pharma, Inc. | Ellis Andrea | Director | Grant | $363.7K |
| Jun 24 | BBIO BridgeBio Pharma, Inc. | MOMTAZEE JAMES C | Director | Grant | $363.7K |
| Jun 24 | BBIO BridgeBio Pharma, Inc. | Valantine Hannah | Director | Sell | $341.5K |
| Jun 24 | BBIO BridgeBio Pharma, Inc. | Hassan Fred | Director | Grant | $363.7K |
| Jun 24 | BBIO BridgeBio Pharma, Inc. | Dachille Douglas A. | Director | Grant | $363.7K |
| Jun 24 | BBIO BridgeBio Pharma, Inc. | MCCORMICK FRANK | Director | Grant | $363.7K |
| Jun 23 | BBIO BridgeBio Pharma, Inc. | HOMCY CHARLES J | Director | Tax withheld | $52.2K |
| Jun 17 | BBIO BridgeBio Pharma, Inc. | Cook Jennifer E. | Director | Sell | $6.0M |
| Jun 8 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $5.4M |
| May 19 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Exercise | $2.4M |
| May 19 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Tax withheld | $311.7K |
| May 19 | BBIO BridgeBio Pharma, Inc. | Scott Randal W. | Director | Sell | $671.5K |
| May 11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $5.4M |
| May 4 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Sell | $143.2K |
| Apr 13 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $6.0M |
| Mar 20 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | Grant | $0 |
| Mar 20 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Grant | $0 |
| Mar 19 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Award | $2.9M |
| Mar 16 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $5.5M |
| Mar 12 | BBIO BridgeBio Pharma, Inc. | Valantine Hannah | Director | Sell | $624.3K |
| Mar 6 | BBIO BridgeBio Pharma, Inc. | Ellis Andrea | Director | Sell | $4.2M |
| Feb 18 | BBIO BridgeBio Pharma, Inc. | Scott Randal W. | Director | Sell | $754.6K |
| Feb 18 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | Sell | $1.0M |
| Feb 18 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Sell | $37.9K |
| Feb 18 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Exercise | $2.3M |
| Feb 12 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $5.7M |
| Jan 12 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $6.0M |
| Dec 16 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | Tax withheld | $1.0M |
| Dec 16 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Tax withheld | $150.5K |
| Dec 16 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $2.2M |
| Dec 10 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Sell | $148.5K |
| Dec 8 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $5.9M |
| Nov 24 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $1.7M |
| Nov 19 | BBIO BridgeBio Pharma, Inc. | Lo Andrew | Director | Sell | $6.3M |
| Nov 19 | BBIO BridgeBio Pharma, Inc. | Scott Randal W. | Director | Sell | $666.5K |
| Nov 18 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Exercise | $2.2M |
| Nov 18 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Tax withheld | $317.4K |
| Nov 18 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | Sell | $1.1M |
50 filings+